Preparing for the NASH Epidemic: A Call to Action.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
09 2021
Historique:
received: 01 12 2020
revised: 18 04 2021
accepted: 20 04 2021
entrez: 21 8 2021
pubmed: 22 8 2021
medline: 18 1 2022
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are common conditions with a rising burden. Yet there are significant management gaps between clinical guidelines and practice in patients with NAFLD and NASH. Further, there is no single global guiding strategy for the management of NAFLD and NASH. The American Gastroenterological Association, in collaboration with 7 professional associations, convened an international conference comprising 32 experts in gastroenterology, hepatology, endocrinology, and primary care providers from the United States, Europe, Asia, and Australia. Conference content was informed by the results of a national NASH Needs Assessment Survey. The participants reviewed and discussed published literature on global burden, screening, risk stratification, diagnosis, and management of individuals with NAFLD, including those with NASH. Participants identified promising approaches for clinical practice and prepared a comprehensive, unified strategy for primary care providers and relevant specialists encompassing the full spectrum of NAFLD/NASH care. They also identified specific high-yield targets for clinical research and called for a unified, international public health response to NAFLD and NASH.

Identifiants

pubmed: 34416976
pii: S0016-5085(21)00749-6
doi: 10.1053/j.gastro.2021.04.074
pii:
doi:

Types de publication

Consensus Development Conference Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1042.e8

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Fasiha Kanwal (F)

Baylor College of Medicine, Veterans Affairs Health Services Research and Development Service, Center for Innovations in Quality, Effectiveness and Safety, and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

Jay H Shubrook (JH)

Touro University California, College of Osteopathic Medicine, Vallejo, California.

Zobair Younossi (Z)

Inova Health System, Falls Church, Virgina.

Yamini Natarajan (Y)

Baylor College of Medicine, Houston, Texas.

Elisabetta Bugianesi (E)

University of Turin, Turin, Italy.

Mary E Rinella (ME)

Northwestern University, Chicago, Illinois.

Stephen A Harrison (SA)

Pinnacle Clinical Research, San Antonio, Texas.

Christos Mantzoros (C)

Harvard Medical School, Boston, Massachusetts.

Kim Pfotenhauer (K)

Michigan State University, East Lansing, Michigan.

Samuel Klein (S)

Washington University School of Medicine, St Louis, Missouri.

Robert H Eckel (RH)

University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Davida Kruger (D)

Henry Ford Health System, Detroit, Michigan.

Hashem El-Serag (H)

Baylor College of Medicine, Houston, Texas.

Kenneth Cusi (K)

University of Florida and Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida. Electronic address: Kenneth.cusi@medicine.ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH